期刊文献+

CT增强扫描和MRI对原发性肝癌的临床诊断价值 被引量:4

原文传递
导出
摘要 目的探讨电子计算机断层扫描(CT)增强扫描和核磁共振成像(MRI)在诊断原发性肝癌中的临床价值。方法选取2018年1月至2020年1月新化县人民医院收治的疑似原发性肝癌患者70例,所有患者均予手术治疗,术前分别采用CT增强扫描与MRI检查,记录并比较两种检查方法的诊断结果。结果70例疑似原发性肝癌患者中有61例经过手术病理证实为原发性肝癌,CT增强扫描检出准确率为85.71%、灵敏度88.52%、特异度66.67%、阳性预测值94.74%、阴性预测值46.15%;MRI检出准确率为94.29%、灵敏度98.36%、特异度88.89%、阳性预测值98.36%、阴性预测值88.89%;MRI诊断结果特异性和阳性预测值与CT增强扫描结果比较,差异无统计学意义(P>0.05),MRI诊断结果准确度、灵敏度、阴性预测值则明显高于CT增强扫描结果,差异有统计学意义(P<0.05)。结论CT增强扫描和MRI方式在原发性肝癌的诊断中均具有一定的临床价值,但较CT增强扫描而言,MRI诊断的准确性更高,在原发性肝癌诊断中更具优势。
作者 邹文
机构地区 新化县人民医院
出处 《慢性病学杂志》 2020年第9期1387-1388,1391,共3页 Chronic Pathematology Journal
  • 相关文献

参考文献6

二级参考文献40

  • 1Banke A,Naveen B,Krishna,et al.The role of CT and endoscopic ultrasound in pre-operative staging of pancreatic cancer[J].European Journal of Radiology,2007,62:166-169. 被引量:1
  • 2Banke A,Naveen B,Krishna,et al.EUS and/or EUS-guided FNA in patients with CT and/or magnetic resonance imaging findings of enlarged ncreatic head or dilated pancreatic duct with or without a dilated common bile duct[J].Gastrointestinal Endoscopy,2008,68 (2):237-242. 被引量:1
  • 3Adam R,Steven K,Libutti,et al.Advances in the early detection,diagnosis and staging of pancreatic cancer[J].Surgical Oncology,1998,6(3):157-169. 被引量:1
  • 4Sharma B, Martin A, Zerizer I, et al. Positron emission tomo-graphy-computed tomography in liver imaging. Semin Ultrasound CT MR, 2013,34(1) :66-80. 被引量:1
  • 5Bohm B, Voth M, Geoghegan J, et aI. Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors. J Cancer Res Clin Oneol, 2004,130(5) :266-272. 被引量:1
  • 6Talbot JN, Gutman F, Fartoux L, et al. PET/CT in patients with hepatocellular carcinoma using 1-(18) F3 Iluorocholine: Pre- liminary comparison with [(18) F] FDG PET/CT. Eur J Nucl Med Mol Imaging, 2006,33(11) : 1285-1289. 被引量:1
  • 7Salem N, Kuang Y, Corn D, et al. [(Methyl)1-(11)c]-acetate metabolism in hepatocellular carcinoma. Mol Imaging Biol, 2011, 13(1) : 140-151. 被引量:1
  • 8Eckel F, Herrmann K, Schmidt S, et al. Imaging of proliferation in hepatocellular carcinoma with the in vivo marker 18F fluorothy- midine. J Nucl Med, 2009,50(9) :1441-1447. 被引量:1
  • 9Petrowsky H, Wildbrett P, Husarik DB, et al. Impact of inte- grated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangio- carcinoma. J Hepatol, 2006,45(1) :43-50. 被引量:1
  • 10Paudyal B, Oriuchi N, Paudyal P, et al. Clinicopathological pres- entation of varying 18F-FDG uptake and expression of glucose transporter 1 and hexokinase II in cases of hepatocellular carcino- ma and cholangiocellular carcinoma. Ann Nucl Med, 2008, 22 (1) :83-86. 被引量:1

共引文献162

同被引文献48

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部